氯沙坦对肝纤维化鼠细胞外基质的影响

原文传递

导出

作者孟燕妮张桂英李乾

机构地区中南大学湘雅医院消化内科

出处《中华消化杂志》 CAS CSCD 北大核心 2004年第11期698-699,共2页 Chinese Journal of Digestion

基金湖南省卫生厅资助项目 (Y 0 2 0 0 8)

关键词抗肝纤维化药物细胞外基质氯沙坦延缓肝内病理改变逆转胶原 ECM

参考文献4

1Gaca MD, Zhou X, Issa R, et al. Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol, 2003, 22:229-239.
2Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res, 2003, 26:1-9.
3Leroy V, Monier F, Bottari S, et al. Circulating matrix metalloproteinases 1,2,9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PⅢNP and hyaluronic acid. Am J Gastroenterol,
4Tokuda K, Kai H, Kuwahara F, et al. Pressure-independent effects of angiotensin Ⅱ on hypertensive myocardial fibrosis. Hypertension, 2004, 43:499-503.

中华消化杂志

2004年第11期

内容加载中请稍等...